Stock Price Forecast

March 9, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading NantKwest Inc chart...

About the Company

NantKwest (NASDAQ: NK) is an innovative, clinical-stage, immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and infectious diseases. NantKwest is the leading producer of clinical dose forms of off-the-shelf natural killer (NK) cell therapies. The activated NK cell platform is designed to destroy cancer and virally-infected cells. The safety of these optimized, activated NK cells-as well as their activity against a broad range of cancers-has been tested in phase I clinical trials in Canada and Europe, as well as in multiple phase I and II clinical trials in the United States. By leveraging an integrated and extensive genomics and transcriptomics discovery and development engine, together with a pipeline of multiple, clinical-stage, immuno-oncology programs, NantKwest's goal is to transform medicine by bringing novel NK cell-based therapies to routine clinical care. NantKwest is a member of the NantWorks ecosystem of companies.

CEO

Patrick Soon-Shiong

Exchange

NASDAQ/NGS (GLOBAL SELECT MARKET)

Website

https://www.nantkwest.com/

$0M

Total Revenue

148

Employees

$3B

Market Capitalization

-36.51

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NK News

Welcome to Inc.'s Directory of B2B Excellence

4mon ago, source: Inc

They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.

Snap Inc Class A

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tony Tontat

1y ago, source: Benzinga.com

He worked in financial teams to raise funds for public companies like Sorrento Therapeutics, Inc. and NantKwest. Prior to this, he worked as an investment analyst at healthcare- specialist hedge ...

STIHL Inc.

7mon ago, source: Forbes

This company has paid to receive expanded profile features. About STIHL Inc. Virginia-based STIHL Inc. is the U.S. affiliate for the global STIHL group and the manufacturer of the number one ...

Block Inc.

5mon ago, source: Wall Street Journal

1 Day SQ -1.32% DJIA -0.49% S&P 500 -0.65% Technology -1.75% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...

About Inc.com | Everything You Need to Know to Grow and Start Your Business

12y ago, source: Inc

Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...

Starwood Property Trust Inc.

5d ago, source: MarketWatch

Annaly Capital Management Inc. 6.5% Conv. Pfd. Series G-0.10% Annaly Capital Management Inc. Pfd. Series I 0.04% Annaly Capital Management Inc. 6.95% Cum. Redeem. Pfd. Series F-0.12% ...

RWT Redwood Trust, Inc.

4d ago, source: Seeking Alpha

Redwood Trust, Inc., together with its subsidiaries, operates as a specialty finance company in the United States. The company operates through three segments: Residential Consumer Mortgage ...

Apple Inc.

20d ago, source: Wall Street Journal

1 Day AAPL 2.56% DJIA 0.30% S&P 500 1.05% Technology -1.75% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...

Amazon.com, Inc. (AMZN)

1mon ago, source: Yahoo Finance

In response to the escalating challenge of retail shrink, which rose to over $112 billion in 2022, retailers including Target (TGT), Walgreens (WBA) and Home Depot (HD) are investing in AI-powered ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...